Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-10

Clinical Trial Update: The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm [Phase 4]

View source ↗

Summary

Phase 4 trial update on nebivolol in hypertensive patients with coronary vasospasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Coronary Vasospasm | Phase 4 | Status: COMPLETED